SEARCH

SEARCH BY CITATION

REFERENCES

  • Ades LC, Holman KJ, Brett MS, Edwards MJ, Bennetts B. 2004. Ectopia lentis phenotypes and the FBN1 gene. Am J Med Genet Part A 126A: 284289.
  • Attansaio M, Lapini I, Evangelisti L, Lucarini L, Giusti B, Porciani MC, Fattori R, Anichini C, Abbate R, Gensini GF, Pepe G. 2008. FBN1 mutation screening of patients with Marfan syndrome and related disorders: Detection of 46 novel FBN1 mutations. Clin Genet 74: 3946.
  • Booms P, Withers AP, Boxer M, Kaufmann UC, Hagemeier C, Vetter U, Robinson PN. 1997. A novel de novo mutation in exon 14 of the fibrillin-1 gene associated with delayed secretion of fibrillin in a patient with a mild Marfan phenotype. Hum Genet 100: 195200.
  • Collod-Beroud G, Beroud C, Ades L, Black C, Boxer M, Brock DJH, Holman KJ, de Paepe A, Francke U, Grau U, Hayward C, Klein HG, Liu W, Nuytinck L, Peltonene L, Perez ABA, Rantamaki T, Junien C, Boileau C. 1998. Marfan database (third edition): New mutations and new routines for the software. Nucl Acids Res 27: 229233.
  • Comeglio P, Evans AL, Brice G, Cooling RJ, Child AH. 2002. Identification of FBN1 gene mutations in patients with ectopia lentis and marfanoid habitus. Br J Ophthalmol 86: 13591362.
  • De Paepe A, Devereux RB, Dietz HC, Hennekam RCM, Pyeritz RE. 1996. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 62: 417426.
  • Downing AK, Knott V, Werner JM, Cardy CM, Campbell ID, Handford PA. 1996. Solution structure of a pair of calcium-binding epidermal growth factor-like domains: implications for the Marfan syndrome and other genetic disorders. Cell 85: 597605.
  • Faivre L, Collod-Beroud G, Callewaert B, Child A, Loeys BL, Binquet C, Gautier E, Arbustini E, Mayer K, Arslan-Kirchner M, Kiotsekoglous A, Comeglio P, Grasso M, Beroud C, Bonithon-Kopp C, Claustres M, Stheneur C, Bouchot O, Wolf JE, Robinson PN, Ades L, De Backer J, Coucke P, Francke U, de Paepe A, Boileau C, Jondeau G. 2009. Pathogenic FBN1 mutations in 146 adults no meeting clinical diagnostic criteria for Marfan syndrome: Further delineation of type 1 fibrillinopathies and focus on patients with an isolated major criterion. Am J Med Genet Part A 149A: 854860.
  • Faivre L, Collod-Beroud G, Loeys BL, Child A, Binquet C, Gautier E, Callewaert B, Arbustini E, Mayer K, Arslan-Kirchner M, Kiotsekoglou A, Comeglio P, Marziliano N, Dietz HC, Halliday D, Beroud C, Bonithon-Kopp C, Claustres M, Muti C, Plauchu H, Robinson PN, Ades LC, Biggin A, Bennets B, Brett M, Holman KJ, De Backer J, Coucke P, Francke U, de Paepe A, Jondeau G, Boileau C. 2007. Effect of mutation type and location on clinical outcome in 1013 probands with Marfan syndrome or related phenotypes and FBN1 Mutations: An international study. Am J Hum Genet 81: 454466.
  • Gray JR, Davies SJ. 1996. Marfan syndrome. J Med Genet 33: 403408.
  • Hayward C, Brock DJH. 1997. Fibrillin-1 mutations in Marfan syndrome and other type-1 fibrillinopathies. Hum Mutat 10: 415423.
  • Koenig SB, Mieler WF. 1996. Management of ectopia lentis in a family with Marfan syndrome. Arch Ophthalmol 114: 10581061.
  • Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereus RB, Hilhorst-Hofstee Y, Jondeau G, Faivre L, Milewicz DM, Pyeritz RE, Sponseller PD, Wordsworth P, De Paepe AM. 2010. The revised Ghent nosology for the Marfan syndrome. J Med Genet 47: 476485.
  • Loeys BL, Nuytinck L, Delvaux I, De Bie S, De Paepe A. 2001. Genotype and phenotype analysis of 171 patients referred for molecular study of the fibrillin-1 gene FBN1 because of suspected Marfan syndrome. Arch Intern Med 161: 24472454.
  • Nemet AY, Assia EI, Apple DJ, Barequet IS. 2006. Current concepts of ocular manifestations in Marfan syndrome. Surv Ophthalmol 51: 561575.
  • Pereira L, D'Alessio M, Ramirez F, Lynch JR, Sykes B, Pangilinan T, Bonadio J. 1993. Genomic organization of the sequence coding for fibrillin, the defective gene product in Marfan syndrome. Hum Mol Genet 7: 961968.
  • Robinson PN, Booms P, Katzke S, Ladewig M, Neumann L, Palz M, Pregla R, Tiecke F, Rosenberg T. 2002. Mutations of FBN1 and genotype-phenotype correlations in Marfan syndrome and related fibrillinopathies. Hum Mutat 20: 153161.
  • Rommel K, Karck M, Haverich A, von Kodolitsch Y, Rybczynski M, Muller G, Singh KK, Schmidtke J, Arslan-Kirchner M. 2005. Identification of 29 novel and nine recurrent fibrillin-1 (FBN1) mutations and genotype-phenotype correlations in 76 patients with Marfan syndrome. Hum Mutat 26: 529539.
  • Schrijver I, Liu W, Brenn T, Furthmayr H, Francke U. 1999. Cysteine substitutions in epidermal growth factor-like domains of fibrillin-1: Distinct effects on biochemical and clinical phenotypes. Am J Hum Genet 65: 10071020.
  • Turner CLS, Emery H, Collins AL, Howarth RJ, Yearwood CM, Cross E, Duncan PJ, Bunyan DJ, Harvey JF, Foulds NC. 2009. Detection of 53 FBN1 mutations (41 novel and 12 recurrent) and genotype-phenotype correlations in 113 unrelated probands referred with Marfan syndrome, or a related fibrillinopathy. Am J Med Genet Part A 149A: 161170.